EQT has agreed to acquire a majority stake in healthcare technology provider Certara from Arsenal Capital Partners for $850 million. Arsenal is keeping a minority stake in the target.
Certara, headquartered in Princeton, New Jersey, provides software and consulting services to the biopharmaceutical industry. Certara's technology uses model simulations to help improve drug development and patient outcomes. In addition, the target advises clients on regulatory processes. Certara serves 1,200 commercial companies, 250 academic institutions. Arsenal acquired Certara in 2013.